Trial intelligence / Profile preview

Lidocaine and Dexmedetomidine for Quality of Recovery After Laparoscopic Total Hysterectomy

NCT04706767Completed

Sponsor
Anqing Municipal Hospital
Start
Jan 2021
Primary completion
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of Lidocaine Hydrochloride Injection, without epinephrine and dexmedetomidine in postoperative recovery (4 arms), sponsored by Anqing Municipal Hospital. Primary endpoint: Quality of Recovery-40 Score. Started Jan 2021; status: completed.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrinedexmedetomidine
03

Conditions

postoperative recovery

Beyond the preview

Go deeper on NCT04706767.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04706767.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call